CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and Knee Cartilage Regeneration

N
News Editor
2026-06-30 23:01:05
In a comprehensive interview with Galaxy, Binance founder CZ shares his views on market cycles, the convergence of crypto and traditional finance, decentralization, Layer 2 vs Layer 1, Hyperliquid's innovation, prediction markets like Polymarket, and his personal investment philosophy. He believes the current cycle bottom is significantly higher than previous lows (BTC support around $60k), and industry leverage is better controlled. Crypto and TradFi will inevitably merge, with centralization and decentralization coexisting. CZ reveals Yzi Labs' investment heuristic: 70% crypto, 20% AI, 10% biotech, including investments in an artificial womb company (tested on mice, human application 5-10 years away) and knee cartilage regeneration technology (3D-printed scaffold). He also compares Chinese and US AI models, emphasizing that AI regulation is far more complex than crypto, and that the future financial system will be built collaboratively by AI, blockchain, and the internet.
BinanceCZmarket cycleAI investmentbiotechdecentralizationprediction marketsL1 vs L2

Market Cycle: Bottom Rises, $60k as Key Support

CZ asserts the four-year cycle pattern remains valid. Current price drawdown is ~50%, far less than the 80% declines of previous cycles (e.g., BTC falling to $16k after Luna collapse and FTX crash in 2022). Now BTC is 4-5x higher, and each cycle starts from a higher base. Technically, historical highs (e.g., $60k) often become future support, but CZ admits he is not a skilled technical analyst and avoids predicting bottoms or duration.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

This cycle differs with state-level backing, institutional adoption (BlackRock), BNB ETF listings, stablecoin issuance, and RWA innovation. Cycles do not end at the same level; it's a spiral with rising bottoms.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

Institutional Leverage: No Defaults, Risks Controlled

Regarding high-leverage products, CZ notes no institution has disclosed near-bankruptcy in the past six months. Despite some high-yield stablecoin circular lending products, their scale is small relative to the overall industry size, making risks manageable.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

Crypto-TradFi Convergence: Not a Separate Industry

CZ views crypto as a new technology enabling fast, low-cost, transparent financial transactions. Traditional finance can use blockchain; crypto companies can offer lending, savings, stock trading, and payments. The two should not be segmented; they will converge into fintech. On centralization vs decentralization, any platform or team has centralized elements, but technology drives decentralization. Centralized players that offer cheap, secure services will attract users via network effects. Both will coexist forever, though CZ is a strong proponent of decentralization.

L2 vs L1 Future: L1 Dominates, L2 as Transition

CZ compares BNB Chain and Ethereum. He advises developers to avoid major upgrades during bull markets; do them in calm bear markets. BNB Chain is developing a faster, cheaper version with more privacy controls. On Ethereum L2s, CZ believes Vitalik has realized L2s don't help L1; after ETH price decline, Vitalik refocused on L1. While strong L2 solutions exist, the long-term future is L1—as L1 speed increases, demand rises, leading to new L2-like solutions, forming an L1-L2 cycle.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

Hyperliquid: Innovative Niche, Binance Cannot Compete

CZ calls Hyperliquid interesting, with founder Jeff having been part of Yzi Labs' early incubation. It proves a new, previously non-existent market segment—no KYC, claiming decentralization (via smart contract deposits/withdrawals), occupying a niche Binance cannot compete in. Despite a small team, the technological innovation is quite good.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

Prediction Market Polymarket: Good Tools, CFTC Support

CZ sees prediction markets as a great invention. The CFTC chair's tone supports them, and many US government figures back Polymarket. Such tools provide price discovery and liquidity, benefiting consumers and the industry. There are already 100-1000 prediction market projects, and more will emerge. He hopes all execute responsibly.

Yzi Labs Portfolio: 70% Crypto, 20% AI, 10% Biotech

CZ reveals Yzi Labs' investment heuristic: ~70% crypto, 20% AI, 10% biotech. Philosophy: impact over ROI. Example: investing billions in a cheap cancer cure may lose money but cure millions; he'd rather lose that investment. Invested projects include: an artificial womb company (tested on pregnant mice, human application 5-10 years away), knee cartilage regeneration (3D-printed scaffold implanted to stimulate growth, early clinical stage). CZ says biotech firms excite him most.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

AI Usage: Multiple Models, US vs China

CZ uses almost all phone AIs: OpenAI, Anthropic/Claude for coding. Traveling reveals some AIs are unavailable in certain countries (e.g., US AIs don't work in Hong Kong). He finds US LLMs more accurate; Chinese models (Deepseek, Kimi) are decent but less comprehensive. CZ notes AI competition is national—both US and China develop chips and data centers. Competition can accelerate progress, but AI is far more dangerous than crypto—it can hack computers, design nuclear weapons, and regulation is difficult. Crypto cannot destroy civilization, but AI might if misused.

CZ Deep Dive: Crypto Cycle Bottom Rises, 70% Allocation to Crypto, 20% AI, 10% Biotech; Invests in Artificial Womb and K

Crypto's Future: Not Dying, AI+Blockchain Build New Finance

CZ firmly believes crypto will not die and will become a huge industry. While hot money flows to AI, people trade AI stocks via crypto, and AI contributes to crypto trading volume. Current payment systems don't support AI (need 2FA, passport KYC); blockchain is API-driven and friendlier to AI. Future financial systems will be built collaboratively by AI, blockchain, and internet. Even if some money goes to AI, eventually all money will flow on blockchains.

This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan.
300

Disclaimer:

The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.

Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.